SPA
CLPT icon

Sherbrooke Park Advisers’s ClearPoint Neuro CLPT Stock Holding History

Sherbrooke Park Advisers’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,181
Closed -$92.6K – 953
2024
Q2 		$92.6K Buy
+17,181
New +$99.4K 0.02% 844

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Sherbrooke Park Advisers's CLPT Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 17,181 shares — an estimated $92.6K sold.

Sherbrooke Park Advisers first reported a position in CLPT in Q2 2024 and held it in 1 quarter. The position peaked at $92.6K in Q2 2024. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 17,181 ClearPoint Neuro shares in Q3 2024, an estimated $92.6K.
  • Sherbrooke Park Advisers first reported a position in ClearPoint Neuro in Q2 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's ClearPoint Neuro position peaked at $92.6K in Q2 2024.
  • 78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.